These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6445095)

  • 1. The binding of plasmin-streptokinase complex to fibrin monomer-sepharose.
    Cederholm-Williams SA
    Thromb Res; 1980 Feb 1-15; 17(3-4):573-6. PubMed ID: 6445095
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.
    Bok RA; Mangel WF
    Biochemistry; 1985 Jun; 24(13):3279-86. PubMed ID: 3161540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of the reactions between streptokinase, plasmin and alpha 2-antiplasmin.
    Cederholm-Williams SA; De Cock F; Lijnen HR; Collen D
    Eur J Biochem; 1979 Oct; 100(1):125-32. PubMed ID: 158524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The conversion of streptokinase-plasminogen complex to SK-plasmin complex in the presence of fibrin or fibrinogen.
    Takada Y; Takada A
    Thromb Res; 1989 Apr; 54(2):133-9. PubMed ID: 2526391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epsilon amino caproic acid inhibits streptokinase-plasminogen activator complex formation and substrate binding through kringle-dependent mechanisms.
    Lin LF; Houng A; Reed GL
    Biochemistry; 2000 Apr; 39(16):4740-5. PubMed ID: 10769130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic studies on the interaction of streptokinase and other plasminogen activators with plasminogen and fibrin.
    Fears R; Hibbs MJ; Smith RA
    Biochem J; 1985 Jul; 229(2):555-8. PubMed ID: 4041182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
    Anonick PK; Vasudevan J; Gonias SL
    Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoaffinity labeling of functionally different lysine-binding sites in human plasminogen and plasmin.
    Ryan TJ; Keegan MC
    Biochim Biophys Acta; 1985 Aug; 830(2):187-94. PubMed ID: 3160389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of nonproteolytic active site formation in plasminogen.
    Gladysheva IP; Sazonova IY; Houng A; Hedstrom L; Reed GL
    Biochemistry; 2007 Jul; 46(30):8879-87. PubMed ID: 17616171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of streptokinase on the fibrin binding site of plasmin(ogen).
    Cederholm-Williams SA
    Thromb Res; 1981 Mar; 21(6):649-54. PubMed ID: 6455776
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of fibrin binding and activation of plasminogen by staplabin through induction of a conformational change in plasminogen.
    Takayasu R; Hasumi K; Shinohara C; Endo A
    FEBS Lett; 1997 Nov; 418(1-2):58-62. PubMed ID: 9414095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-D-val-leu-lys-aminoisophthalic acid, dimethyl ester, is sensitive to streptokinase-activator not to plasmin.
    Ts'ao C; Galluzzo TS
    Am J Clin Pathol; 1981 Mar; 75(3):372-7. PubMed ID: 6452054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin binding. An essential property of anisoylated plasminogen streptokinase activator complex.
    Banton CJ; Overell BG
    Drugs; 1987; 33 Suppl 3():93-6. PubMed ID: 2824169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the interaction of group A streptococci with fibrinogen, streptokinase and plasminogen.
    Wang H; Lottenberg R; Boyle MD
    Microb Pathog; 1995 Mar; 18(3):153-66. PubMed ID: 7565010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a human plasmin-derived, functionally active, light (B) chain capable of forming with streptokinase an equimolar light (B) chain-streptokinase complex with plasminogen activator activity.
    Summaria L; Robbins KC
    J Biol Chem; 1976 Sep; 251(18):5810-13. PubMed ID: 134997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.
    Sakai M; Watanuki M; Matsuo O
    Biochem Biophys Res Commun; 1989 Jul; 162(2):830-7. PubMed ID: 2527034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrodynamic studies on the streptokinase complexes of human plasminogen, Val442-plasminogen, plasmin, and the plasmin-derived light (B) chain.
    Barlow GH; Summaria L; Robbins KC
    Biochemistry; 1984 May; 23(11):2384-7. PubMed ID: 6236844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of plasminogen, plasmin and streptokinase-plasminogen activator to fibrin [proceedings].
    Cederholm-Williams SA
    Biochem Soc Trans; 1977; 5(5):1441-3. PubMed ID: 144626
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of fibrinogen degradation products and some lysine analogues on the dissociation of plasmin(ogen)-fibrin complexes.
    Cederholm-Williams SA; Swain A
    Thromb Res; 1979; 16(5-6):705-13. PubMed ID: 160626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.